Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Donepezil hydrochloride
Drug ID BADD_D00707
Description In 2016, the global burden of dementia was estimated to be 43.8 million, demonstrating a significant increase from a global prevalence of 20.2 million in 1990.[A182411] Donepezil, also known as Aricept, is a piperidine derivative acetylcholinesterase inhibitor used in the management of the dementia of Alzheimer's Disease, and in some cases, is used to manage other types of dementia. Donepezil was first approved by the FDA in 1996, and its extended-release form was approved in combination with [Memantine] in 2014 to manage moderate and severe forms of Alzheimer's dementia.[L7916,L7937] Though it does not alter the progression of Alzheimer's disease, donepezil is effective in managing the symptoms of its associated dementia.[T668]
Indications and Usage For the palliative treatment of mild to moderate dementia of the Alzheimer's type.
Marketing Status Prescription; Discontinued
ATC Code N06DA02
DrugBank ID DB00843
KEGG ID D00670
MeSH ID D000077265
PubChem ID 5741
TTD Drug ID D0NS6H
NDC Product Code 55111-302; 62856-245; 62856-247; 69844-038; 42291-246; 68382-521; 65841-163; 60687-303; 60510-614; 60429-321; 42582-312; 68382-347; 68071-3198; 46708-296; 62756-789; 46708-295; 68180-527; 71093-127; 71093-128; 11071-842; 62147-0050; 33342-061; 72189-265; 63629-1118; 68071-3396; 68071-4615; 55289-151; 68788-7732; 29300-249; 43063-659; 33342-029; 0904-6478; 64380-907; 60429-322; 63629-8483; 68071-1523; 68071-4613; 71335-0876; 62756-194; 0781-5277; 62147-0011; 65038-055; 71209-020; 50090-3537; 11071-871; 55486-1590; 71335-0900; 24979-004; 50090-2910; 29300-250; 0615-7951; 65096-0109; 71335-0792; 53104-7728; 59746-330; 43547-276; 71335-0582; 43547-275; 29300-248; 58032-0137; 55154-7883; 55111-356; 0904-6477; 64380-908; 43547-382; 65862-326; 42582-311; 33342-030; 71335-2022; 72189-031; 31722-738; 70771-1320; 71209-019; 65841-749; 65038-056; 62332-092; 59746-329; 53747-026; 63629-8050; 69844-037; 65862-429; 64220-101; 53104-7729; 31722-737; 68071-1700; 71335-0416; 63187-401; 66577-022; 68382-346; 62856-246; 60687-292; 68071-1572; 16571-779; 70518-0452; 50228-140; 55111-357; 58623-0116; 65841-721; 50228-139; 33342-027; 65841-722; 0615-8313; 65862-325; 51407-320; 0781-5276; 62332-093; 33342-028; 71205-948; 70518-1666; 16571-778; 13668-103; 60510-613; 71335-2065; 65841-750; 13668-102; 29300-251; 63629-1117; 55154-7882; 61919-692; 11071-841; 50090-2627
Synonyms Donepezil | Eranz | Donepezilium Oxalate Trihydrate | E 2020 | E2020 | E-2020 | Donepezil Hydrochloride | 1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride | Aricept
Chemical Information
Molecular Formula C24H30ClNO3
CAS Registry Number 120011-70-3
SMILES COC1=C(C=C2C(=C1)CC(C2=O)CC3CCN(CC3)CC4=CC=CC=C4)OC.Cl
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
AstheniaCholinesteraseP06276T99799Not Available
DiarrhoeaCholinesteraseP06276T99799Not Available
DizzinessCholinesteraseP06276T99799Not Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Abdominal distension07.01.04.001--
Abdominal pain07.01.05.002--
Abnormal dreams19.02.03.001; 17.15.02.001--Not Available
Abscess11.01.08.001--Not Available
Accident12.01.08.001--Not Available
Aggression19.05.01.001--Not Available
Agitation19.06.02.001; 17.02.05.012--
Alanine aminotransferase increased13.03.01.003--
Albuminuria20.02.01.001--Not Available
Alopecia23.02.02.001--
Anaemia01.03.02.001--
Anaemia vitamin B12 deficiency14.12.02.001; 01.03.01.001--Not Available
Angina pectoris24.04.04.002; 02.02.02.002--
Anxiety19.06.02.002--
Apathy19.04.04.002--Not Available
Aphasia19.21.01.001; 17.02.03.001--
Arteritis24.05.01.001--Not Available
Arthralgia15.01.02.001--
Arthritis15.01.01.001--
Aspartate aminotransferase increased13.03.01.006--
Asthenia08.01.01.001--Not Available
Asthma22.03.01.002; 10.01.03.010--Not Available
Ataxia08.01.02.004; 17.02.02.001--
Atrial fibrillation02.03.03.002--
Atrioventricular block02.03.01.002--Not Available
Back pain15.03.04.005--
Benign prostatic hyperplasia21.04.02.001--Not Available
Blepharitis06.04.04.001; 23.03.04.012--Not Available
Blood creatine phosphokinase13.04.01.009--Not Available
Blood creatine phosphokinase increased13.04.01.001--
The 1th Page    1 2 3 4 5    Next   Last    Total 9 Pages